Overview

Study Evaluating Single Doses of PPM-204 on the Electrical Pathways of the Heart

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
A study evaluating the safety of a high and low dose of PPM-204 on the electrical pathways of the heart.
Phase:
Phase 1
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer